Effects of Rifamycin Sodium Injection Combined with Linezolid Injection on Inflammatory Response,Serum Procalcitonin and Adverse Drug Reactions in Patients with Severe Gram-Positive Coccus Infection

CHEN Peili; YANG Lin; ZHANG Hui; LIU Huili; MA Tongshuai

doi:10.14009/j.issn.1672-2124.2020.04.011

您当前的位置：

首页 >

文章列表页 >

Effects of Rifamycin Sodium Injection Combined with Linezolid Injection on Inflammatory Response,Serum Procalcitonin and Adverse Drug Reactions in Patients with Severe Gram-Positive Coccus Infection

更新时间：2022-10-08

- Effects of Rifamycin Sodium Injection Combined with Linezolid Injection on Inflammatory Response,Serum Procalcitonin and Adverse Drug Reactions in Patients with Severe Gram-Positive Coccus Infection
- Vol. 20, Issue 4, Pages: 425-427(2020)
- 作者机构：
  
  1. 商丘市第一人民医院重症监护室
  2. 商丘市第一人民医院儿科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.04.011
  CLC： R515
- Published：2020，
扫描看全文
[1]陈培莉,杨林,张辉,刘慧丽,马统帅.利福霉素钠注射液联合利奈唑胺注射液对重症革兰阳性球菌感染患者炎症反应、血清降钙素原水平及不良反应的影响[J].中国医院用药评价与分析,2020,20(04):425-427+431.

CHEN Peili, YANG Lin, ZHANG Hui, et al. Effects of Rifamycin Sodium Injection Combined with Linezolid Injection on Inflammatory Response,Serum Procalcitonin and Adverse Drug Reactions in Patients with Severe Gram-Positive Coccus Infection. [J]. 20(4):425-427(2020)
[1]陈培莉,杨林,张辉,刘慧丽,马统帅.利福霉素钠注射液联合利奈唑胺注射液对重症革兰阳性球菌感染患者炎症反应、血清降钙素原水平及不良反应的影响[J].中国医院用药评价与分析,2020,20(04):425-427+431. DOI： 10.14009/j.issn.1672-2124.2020.04.011.

CHEN Peili, YANG Lin, ZHANG Hui, et al. Effects of Rifamycin Sodium Injection Combined with Linezolid Injection on Inflammatory Response,Serum Procalcitonin and Adverse Drug Reactions in Patients with Severe Gram-Positive Coccus Infection. [J]. 20(4):425-427(2020) DOI： 10.14009/j.issn.1672-2124.2020.04.011.

摘要

目的:探讨利福霉素钠注射液联合利奈唑胺注射液对重症革兰阳性球菌感染患者炎症反应、血清降钙素原（PCT）水平及不良反应的影响。方法:选取2018年5月至2019年9月商丘市第一人民医院收治的重症革兰阳性球菌感染患者60例作为研究对象

按照随机数字表法分为研究组和对照组

每组30例。对照组患者给予利奈唑胺注射液治疗

研究组患者在对照组的基础上给予利福霉素钠注射液治疗。比较两组患者的临床疗效、炎症指标[白细胞计数（WBC）、超敏C反应蛋白（hs-CRP）、白细胞介素1β（IL-1β）及白细胞介素10（IL-10）]水平、血清PCT水平及不良反应发生情况的差异。结果:研究组患者的总有效率明显高于对照组[90. 00%（27/30） vs. 66. 67%（20/30）]

差异有统计学意义（P <0. 05）。治疗后

两组患者血清WBC、CRP及IL-1β水平均较治疗前明显降低

血清IL-10水平较治疗前明显升高;且研究组患者血清WBC、CRP及IL-1β水平明显低于对照组

血清IL-10水平明显高于对照组

上述差异均有统计学意义（P <0. 05）。治疗后

两组患者血清PCT水平均较治疗前明显降低

且研究组患者明显低于对照组

差异均有统计学意义（P <0. 05）。研究组、对照组患者的不良反应发生率分别为23. 33%（7/30）、26. 67%（8/30）

差异无统计学意义（P> 0. 05）。结论:利福霉素钠注射液联合利奈唑胺注射液治疗重症革兰阳性球菌感染的临床效果显著

能够有效降低患者血清PCT水平

改善炎症反应

缓解感染症状

具有一定的临床应用价值。

Abstract

OBJECTIVE: To probe into the effects of rifamycin sodium injection combined with linezolid injection on inflammatory response

serum procalcitonin（ PCT） and adverse drug reactions in patients with severe gram-positive coccus infection. METHODS: Totally 60 patients with severe gram-positive coccus infection admitted into Shangqiu First People’s Hospital from May 2018 to Sept. 2019 were extracted to be divided into the study group and the control group via the random number table

with 30 cases in each group. The control group was treated with linezolid injection

while the study group additionally received rifamycin sodium injection based on the control group.Differences of clinical efficacy

levels of inflammatory indexes [white blood cell count（ WBC）

high-sensitivity Creactive protein（ hs-CRP）

interleukin 1β（ IL-1β） and interleukin 10（ IL-10） ]

levels of serum PCT and adverse drug reactions of two groups were compared. RESULTS: The total effective rate in the study group was significantly higher than that in the control group [90. 00%（ 27/30） vs. 66. 67%（ 20/30） ]

and the difference was statistically significant（ P < 0. 05）. After treatment

the levels of serum WBC

CRP and IL-1β in two groups were significantly lower than those before treatment

and the levels of serum IL-10 were significantly higher than those before treatment;the levels of WBC

CRP and IL-1β in the study group were significantly lower than those in the control group

and the levels of IL-10 were significantly higher than those in the control group

differences were statistically significant（ P <0. 05）. After treatment

the levels of serum PCT of two groups was significantly lower than those before treatment

and the study group was significantly lower than the control group

with statistically significant differences（ P < 0. 05）.The incidence of adverse drug reactions in the study group and the control group were 23. 33%（ 7/30） and 26. 67%（ 8/30）

respectively

with no statistically significant difference（ P > 0. 05）. CONCLUSIONS: The clinical efficacy of rifamycin sodium injection combined with linezolid injection is remarkable

which can significantly reduce the levels of serum PCT

improve the inflammatory response of patients

relief the infection symptoms and has certain clinical application value.

关键词

利奈唑胺利福霉素钠重症革兰阳性球菌感染疗效不良反应

Keywords

LinezolidRifamycin sodiumSevere gram-positive coccus infectionEfficacyAdverse drug reactions

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Self-Made Wenyang Tongluo Decoction in the Treatment of Diabetic Peripheral Neuropathy of Yang-Deficiency and Blood-Stasis SyndromeΔ

Systematic Review of Efficacy and Safety of Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor in the Treatment of Burn Wounds

Clinical Research on Xingnaojing Injection Combined with Cattle Encephalon Glycoside and Ignotin Injection in the Treatment of Acute Stroke

Comparison of Efficacy and Safety of Linezolid and Vancomycin in the Treatment of Neonatal Gram-Positive Coccal Pneumonia

Blood Trough Concentration Monitoring and Efficacy of Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection

Related Author

ZHAO Jun

ZHANG Qiujin

XU Junfei

ZHENG Dongjie

LIU Na

LIU Xiaobiao

LI Guixin

LI Hongtao

Related Institution

Dept.of Endocrinology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dept. of Anesthesiology, Binhai Hospital, Tianjin Medical University General Hospital

Dept. of Community Medicine, Xiaodian Hospital of Tianjin

Dept. of Surgery, Second Hospital of Hebei Medical University

Dept.of ICU,Fuyang People ’s Hospital

⁰